Sponsor:
Physician Affiliate Group of New York
Code:
NCT06876831
Conditions
Lung Cancer Screening Program
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
Interventions
Shared decision making for LDCT (3 potential outcomes LDCT on discharge, scheduled date of LDCT, or Lung Cancer Screening referral)
Inpatient Tobacco Cessation Counseling (Handouts, NYC Quits number, Medication Recommendations to primary team, Smoking cessation referral)
Brief summary:
Conditions
Lung Cancer Screening Program
Study ID
NCT06876831
Start date
Mar 10, 2025
Status verified date
Mar, 2025
Completion date
Dec 31, 2025
Anticipated
Primary completion date
Sep 10, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
Enrollment
150 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Screening
Arms
experimental: Meets LCS criteria and former smoker
experimental: Meets LCS criteria and active smoker
Interventions
Shared decision making for LDCT (3 potential outcomes LDCT on discharge, scheduled date of LDCT, or Lung Cancer Screening referral)
Inpatient Tobacco Cessation Counseling (Handouts, NYC Quits number, Medication Recommendations to primary team, Smoking cessation referral)
Primary outcome measure
Central contacts
Locations
Metropolitan Hospital/ NYCHHC
Recruiting
New York, New York, United States, 11362
Contacts
Hyewon Shin, NP
Hyewon.Shin@nychhc.orgPrincipal Investigator:
Natoushka Trenard, MD, MPH
Sponsor
Physician Affiliate Group of New York
Last update posted
Mar 14, 2025
Last verified
Mar, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Physician Affiliate Group of New York on 2025-03-14.